Sort
35,931 grants matching “parkinsons”
Clinical, Genetic, And Cellular Consequences of Mutations in Na,K-ATPase ATP1A3
$636,369Allison Brashear · Wake Forest University Health Sciences · R01 · FY2009 · NS
Olfactory and neurological manifestations of acute and post-acute murine COVID-19
$636,357Stanley Perlman · University Of Iowa · R01 · FY2025 · AI
Neuroinflammatory Biomarkers for Nigrostriatal Injury
$636,339Joel Synes Perlmutter · Washington University · R01 · FY2022 · NS
Significance of Protein Synthesis by the Integrated Stress Response in Neuromodulatory Neurons for Adaptive Behavior and Synaptic Plasticity
$636,300Nicole Calakos · Duke University · R01 · FY2023 · NS
Molecular Mechanisms of Estrogen Action in Sex Organ Development
$636,234Christina Tu Teng · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Exploiting Dopamine Receptor Functional Selectivity as an Approach to Treat Parkinson's Symptoms
$636,146Marc G. Caron · Duke University · R01 · FY2021 · NS
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons
$635,925Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2025 · NS
Identifying Circuit Dynamics Underlying Motor Dysfunction in ParkinsonÂs Disease Using Real-Time Neural Control
$635,904David Escobar Sanabria · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Biomarker signatures of biological, chemical, or psychological stress
$635,858David A Lawrence · Wadsworth Center · U01 · FY2009 · ES
IDENTIFICATION OF AXONAL DEGENERATION PATHWAYS
$635,834Aaron Diantonio · Washington University · R01 · FY2012 · NS
Human Embryonic Stem Cells: Characterization and Dopaminergic Differentiation
$635,708William Freed · National Institute On Drug Abuse · ZIA · FY2014 · DA
Advanced MRI studies of cerebrovascular and lymphatic abnormalities in LRRK2 mouse models of Parkinson's disease
$635,611Wanli W Smith · Johns Hopkins University · R01 · FY2022 · NS
Clinical, Genetic, and Cellular Consequences of Mutations In NA,K-ATPase ATP1A3
$635,579Allison Brashear · State University Of New York At Buffalo · R01 · FY2025 · NS
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
$635,495Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2020 · AG
Regulation of Motor Function in Parkinson's Disease
$635,472Stella M Papa · Emory University · R01 · FY2019 · NS
Systematic investigation of disease-associated, regulatory variation; illuminating their prediction, molecular consequences and mechanisms contributing to risk of Parkinson disease (PD)
$635,430Andrew S McCallion · Johns Hopkins University · R01 · FY2024 · NS
Biometric Instrument to Monitor Neurological Disorders
$635,351Ruth Shrairman · Verifax Corporation · R44 · FY2009 · NS
Small molecule modulators of ÎFosB function
$635,178Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2016 · DA
Nitroxides as Protectors Against Oxidative Stress
$635,139James B Mitchell · Clinical Sciences · Z01 · FY2007 · CA
Next-generation antisense therapeutics for ALS and frontotemporal dementia
$635,090Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · NS
Next-generation antisense therapeutics for ALS and frontotemporal dementia
$635,090Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · NS
Next-generation antisense therapeutics for ALS and frontotemporal dementia
$635,090Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · NS
Next-generation antisense therapeutics for ALS and frontotemporal dementia
$635,090Jonathan K Watts · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · NS
The Pathophysiology of Network Synchrony in Parkinson's Disease
$635,036Nader Pouratian · Ut Southwestern Medical Center · R01 · FY2024 · NS
Higher Speed, Field and Spatial Resolution Brain 3D 1H MRS
$635,016Oded Gonen · New York University School Of Medicine · R01 · FY2009 · EB